This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hvidovre Hospital. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Keven Lothert - Innovator in Virus Purification
Introduction
Keven Lothert is an inventor based in Giessen, Germany. He has made significant contributions to the field of virus purification, particularly in relation to hepatitis C virus (HCV) particles. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical research and treatment.
Latest Patent Applications
Keven Lothert's latest patent application is titled "Method of Purifying Whole Virus Particles." This invention relates to a method of purifying whole HCV particles, which includes several steps: a) providing a cell culture supernatant comprising virus particles, b) purification and/or concentration of the cell culture supernatant, c) purification and/or concentration of the product of step b) using steric exclusion chromatography (SXC) at alkaline pH in the range of 8-10, d) purification and/or concentration of the product of step c) using sulphated cellulose membrane absorbers (SCMA), and e) obtaining purified whole virus particles.
Conclusion
Keven Lothert's innovative approach to virus purification showcases his dedication to advancing medical science. His work has the potential to contribute significantly to the field, despite the absence of granted patents at this time.